12:00 AM
 | 
Oct 23, 2014
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Cancer
Myelodysplastic syndrome (MDS) Casein kinase 1 (CSNK1; CKI) In...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >